Home > Financial Ratios > SUN PHARMACEUTICAL INDUSTRIES

SUN PHARMACEUTICAL INDUSTRIES
EV/Core EBITDA

    Back to All Ratios
SUN PHARMACEUTICAL INDUSTRIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
Best 1M Momentum Large Cap Stocks
COMMUNITY POLL
for SUN PHARMACEUTICAL INDUSTRIES
Please provide your vote to see the results

SUN PHARMACEUTICAL INDUSTRIES Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 26.5119.2419.0315.1011.32

What is the latest EV/Core EBITDA ratio of SUN PHARMACEUTICAL INDUSTRIES ?

The latest EV/Core EBITDA ratio of SUN PHARMACEUTICAL INDUSTRIES is 26.51 based on Mar2024 Consolidated results.
Year EV/Core EBITDA
Mar202426.51
Mar202319.24
Mar202219.03
Mar202115.10
Mar202011.32

How is EV/Core EBITDA of SUN PHARMACEUTICAL INDUSTRIES Trending?

Years EV/Core EBITDA % Change
Mar2024 26.51
37.79
Mar2023 19.24
1.10
Mar2022 19.03
26.03
Mar2021 15.1
33.39
Mar2020 11.32 -

Other Financial Ratios of SUN PHARMACEUTICAL INDUSTRIES


Compare EV/Core EBITDA ratio of peers of SUN PHARMACEUTICAL INDUSTRIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SUN PHARMACEUTICAL INDUSTRIES ₹443,018.7 Cr -0.4% 4.7% 60.2% Stock Analytics
DIVIS LABORATORIES ₹144,299.0 Cr -1.1% 11% 43.2% Stock Analytics
CIPLA ₹132,316.0 Cr -1.3% 2.8% 33.9% Stock Analytics
DR REDDYS LABORATORIES ₹108,579.0 Cr -2.3% -7.8% 14.4% Stock Analytics
ZYDUS LIFESCIENCES ₹106,092.0 Cr -5.7% -12.6% 68.7% Stock Analytics
MANKIND PHARMA ₹97,396.6 Cr -2.7% 6.6% 33.4% Stock Analytics


SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SUN PHARMACEUTICAL INDUSTRIES

-0.4%

4.7%

60.2%

SENSEX

0.3%

3%

23.3%


You may also like the below Video Courses